The Human Fertilisation and Embryology Authority, the regulator for fertility treatment and embryo research, is adding its experience to the Government blueprint for new fertility legislation with its submission to the Department of Health's consultation on the Review of the Human Fertilisation and Embryology Act 1990.
Speaking at the Progress Educational Trust conference on stem cell research in London today, Suzi Leather, Chair of the HFEA, said that researchers must continue to be engaged with public opinion to provide confidence about the work that they are doing, reassuring people that their research is beneficial and appropriate.
A public debate on how far doctors and scientists should be allowed to go with embryo-testing techniques is being launched today by the UK fertility regulator, the Human Fertilisation and Embryology Authority (HFEA).
The public believes the benefits of fertility treatment outweigh the risks but around half still feel that it has unknown consequences in the long-term, according to studies of public and patient opinion for the Human Fertilisation and Embryology Authority.
The Human Fertilisation and Embryology Authority (HFEA) can announce the appointment of two new Authority members, David Archard and Ruth Fasht, who have been selected by the NHS Appointments Commission along with the reappointment of Sharmila Nebhrajani who will also become the Authority's Deputy Chair.
A better system for protecting the welfare of children born as a result of fertility treatment has been announced today by the Human Fertilisation and Embryology Authority (HFEA).
Today's sperm donors are much more likely to be family men in their 30s than the old stereotype of hard-up medical students, according to a new analysis of the people coming forward as sperm and egg donors by the Human Fertilisation and Embryology Authority (HFEA).
The Human Fertilisation and Embryology Authority (HFEA) has today (8 Sep 05) granted a licence to the Newcastle Centre at LIFE for the use of embryos for research into Mitochondrial Disease (details of the project can be found in the Research section of the HFEA website).
The Human Fertilisation and Embryology Authority (HFEA) has announced today that it is to seek the public's views on the appropriateness of using fertility treatment technology to screen out serious genetic disorders such as inherited breast cancer.
The Human Fertilisation and Embryology Authority (HFEA), the UK regulator for fertility treatment, is looking to reduce the risks of fertility treatment and improve outcomes for patients by reviewing the clinical practice around the number of embryos transferred during fertility treatment. (Single embryo transfer, SET, Multiple births)
People seeking fertility treatment are getting extra information and support in one of the most controversial new areas of fertility tests and treatment with a new factsheet from the Human Fertilisation and Embryology Authority (HFEA), the UK regulator for fertility treatment.
The HFEA is launching Fertility Views, an online consultative panel aimed at gaining the views and experiences of people throughout the UK who have had, are undergoing or preparing for fertility treatment to help improve the quality of services across the UK.
The most comprehensive picture of the UK's fertility treatment sector has been published today (Tuesday 24 May) by the Human Fertilisation and Embryology Authority, the regulator for IVF and other licensed fertility treatment.
Suzi Leather, Chair of the HFEA, said: "This radical report is a challenging contribution to the debate about how we should ensure effective regulation of fertility treatment and embryo research in the interests of patients and the public.
The public concerns and future developments which underpin the need for ongoing independent regulation of fertility treatment and research will be spelt out in a keynote speech by Angela McNab, Chief Executive of the Human Fertilisation and Embryology Authority, at the HFEA's annual conference today (15 March).
The future issues in the fertility sector ? empowering patients in their treatment choices, forthcoming scientific developments and the future regulation of the sector ? will be examined in the Human Fertilisation and Embryology Authority's 2005 Annual Conference, ´Looking to the Future', which will be held at the Royal College of Surgeons in London, on Tuesday 15 March.
The Human Fertilisation and Embryology Authority (HFEA) has granted a licence to the Roslin Institute in Edinburgh to create stem cells from embryos produced by cell nuclear replacement, a technique also referred to as therapeutic cloning.
People across the UK are being urged to help shape the future of the system for managing sperm, egg and embryo donation arrangements before a three-month consultation closes on February 4.
The Human Fertilisation and Embryology Authority (HFEA) has announced a new policy to streamline the approval of applications for preimplantation genetic diagnosis (PGD) embryo screening.
The Human Fertilisation and Embryology Authority (HFEA) is launching a wide public consultation into how clinics should protect the interests of children born through fertility treatment. The process includes public consultative meetings, discussions with particular groups ? such as clinic staff and GPs - and the chance for anyone to provide suggestions for the future shape of the guidance.